Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 24

1.

Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation.

Haddock CK, Poston WS, Foreyt JP, DiBartolomeo JJ, Warner PO.

Eat Weight Disord. 2008 Jun;13(2):95-101.

PMID:
18612258
2.

A systematic review of targeted outcomes associated with a medically supervised commercial weight-loss program.

Furlow EA, Anderson JW.

J Am Diet Assoc. 2009 Aug;109(8):1417-21. doi: 10.1016/j.jada.2009.05.003. Review.

PMID:
19631049
3.

Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up.

Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, Bowman JD, Pronk NP.

J Am Diet Assoc. 2007 Oct;107(10):1755-67. Review.

PMID:
17904936
4.

Long-term weight loss: the effect of pharmacologic agents.

Goldstein DJ, Potvin JH.

Am J Clin Nutr. 1994 Nov;60(5):647-57; discussion 658-9. Review.

PMID:
7942569
5.

Pharmacotherapy of obesity.

Linné Y, Rössner S.

Clin Dermatol. 2004 Jul-Aug;22(4):319-24. Review.

PMID:
15475233
6.

Behavior therapy for obesity: where are we now?

Sarwer DB, von Sydow Green A, Vetter ML, Wadden TA.

Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):347-52. doi: 10.1097/MED.0b013e32832f5a79. Review.

PMID:
19623061
7.

Sibutramine: current status as an anti-obesity drug and its future perspectives.

Sharma B, Henderson DC.

Expert Opin Pharmacother. 2008 Aug;9(12):2161-73. doi: 10.1517/14656566.9.12.2161 . Review.

PMID:
18671470
8.

Pharmacotherapy for obesity.

Hensrud DD.

Med Clin North Am. 2000 Mar;84(2):463-76. Review.

PMID:
10793652
9.

Evaluation and treatment of obesity.

Azar ST, Zantout MS.

J Med Liban. 2000 Sep-Oct;48(5):310-4. Review. No abstract available.

PMID:
12489585
10.
11.

A review of weight loss programs delivered via the Internet.

Weinstein PK.

J Cardiovasc Nurs. 2006 Jul-Aug;21(4):251-8; quiz 259-60. Review. Erratum in: J Cardiovasc Nurs. 2007 Mar-Apr;22(2):137.

PMID:
16823276
12.

Medical interventions in adolescent obesity.

Khan UI, Collier M.

Adolesc Med State Art Rev. 2008 Dec;19(3):406-20, viii. Review.

PMID:
19227383
13.

When prevention fails: obesity treatment strategies.

Aronne LJ, Wadden T, Isoldi KK, Woodworth KA.

Am J Med. 2009 Apr;122(4 Suppl 1):S24-32. doi: 10.1016/j.amjmed.2009.01.005. Review.

PMID:
19410674
14.

[Strategies in therapy of obesity].

Hauner H.

Internist (Berl). 1997 Mar;38(3):244-50. Review. German. No abstract available.

PMID:
9173046
15.

The development of tolerance to drugs that suppress food intake.

Fernstrom JD, Choi S.

Pharmacol Ther. 2008 Jan;117(1):105-22. Epub 2007 Sep 20. Review.

PMID:
17950459
16.

Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction.

Pilsczek FH, Karcic AA, Freeman I.

Heart Lung. 2003 Mar-Apr;32(2):100-4. Review.

PMID:
12734532
17.

Evaluating commercial weight loss programmes: an evolution in outcomes research.

Hamilton M, Greenway F.

Obes Rev. 2004 Nov;5(4):217-32. Review.

PMID:
15458396
18.

Anti-obesity drugs.

Kushner RF.

Expert Opin Pharmacother. 2008 Jun;9(8):1339-50. doi: 10.1517/14656566.9.8.1339 . Review.

PMID:
18473708
19.

Behavioral management of obesity.

Johnston CA, Tyler C, Foreyt JP.

Curr Atheroscler Rep. 2007 Dec;9(6):448-53. Review.

PMID:
18377784
20.

Should medicare reimburse providers for weight loss interventions?

Kaplan RM.

Am Psychol. 2007 Apr;62(3):217-9. Review.

PMID:
17469899

Supplemental Content

Support Center